These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain. Zhou Y, Sugiyama H, Johnson EA. Appl Environ Microbiol; 1993 Nov; 59(11):3825-31. PubMed ID: 8285687 [Abstract] [Full Text] [Related]
12. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains. Oguma K, Syuto B, Iida H, Kubo S. Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231 [Abstract] [Full Text] [Related]
13. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain. Rani S, Ponmariappan S, Sharma A, Kamboj DV, Jain AK. Protein Pept Lett; 2017 Dec; 24(6):495-502. PubMed ID: 28260503 [Abstract] [Full Text] [Related]
14. Cloning of a DNA sequence unique to Clostridium botulinum group I by selective hybridization. McKinney MW, Levett PN, Haylock RW. J Clin Microbiol; 1993 Jul; 31(7):1845-9. PubMed ID: 8349762 [Abstract] [Full Text] [Related]
15. Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F H(C) fragment. Foynes S, Holley JL, Garmory HS, Titball RW, Fairweather NF. Vaccine; 2003 Mar 07; 21(11-12):1052-9. PubMed ID: 12559779 [Abstract] [Full Text] [Related]